Skip to main content

Clinical Pathways promote evidence based, safe, and high-value care for patients by providing clinical recommendations and standard processes.  They are developed by multidisciplinary committees of subject matter experts, informed by methodical review of available evidence and consensus among committee members. 

Clinical Pathways: 

Inclusion and exclusion criteria:

Inclusion:

  • Patients > 60 days of age with suspected skin and soft tissue infection

Exclusion:  

Committee members and representation involved in the development: 

  • Megan Hamner, MD | Infectious Diseases | Committee Chair  
  • Rana El Feghaly, MD, MSCI | Infectious Diseases | Committee Member  
  • Erin Scott, DO | Emergency Medicine | Committee Member  
  • Jessica Markham, MD, MSc | Hospital Medicine | Committee Member  
  • Amanda Nedved, MD | Urgent Care | Committee Member  

EBP Committee Members:

  • Katie Berg, MD, FAAP | Evidence Based Practice & Hospital Medicine | Committee member  
  • Kori Hess, PharmD | Evidence Based Practice | Committee member 

Publication dates:

  • Finalized date: 5/2022, 12/2025
  • Next expected revision date: 2028

If you have any question regarding this content, or identify a broken link, please email evidencebasedpractice@cmh.edu. 

These pathways do not establish a standard of care to be followed in every case. It is recognized that each case is different, and those individuals involved in providing health care are expected to use their judgment in determining what is in the best interests of the patient based on the circumstances existing at the time. It is impossible to anticipate all possible situations that may exist and to prepare a pathway for each. Accordingly, these pathways should guide care with the understanding that departures from them may be required at times.